Search research articles
Contact Us
Filters
Showing results (71-80 of 138) with videos related to
Page
of 14
Sort By:
JMIR Formative Research
|
May 5, 2025
Characterizing Patient-Reported Fatigue Using Electronic Diaries in Neurodegenerative and Immune-Mediated Inflammatory Diseases: Observational Study
Adrien Bennetot, Rana Zia Ur Rehman, Robbin Romijnders, et al.
Neuromodulation : Journal of the International Neuromodulation Society
|
April 10, 2023
The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's Syndrome
Jessica Tarn, Evelyn Evans, Emmanuella Traianos, et al.
Lancet (London, England)
|
August 3, 2024
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study
Benjamin A Fisher, Xavier Mariette, Athena Papas, et al.
The Lancet. Rheumatology
|
July 2, 2026
Interferon-α as a precision medicine tool in Sjögren's disease: a cohort and experimental medicine study
Deborah Forbes, Ivana Jorgacevic, Jessica Tarn, et al.
RMD Open
|
April 1, 2025
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis
Leher Gumber, Fiona Rayner, Theophile Bigirumurame, et al.
Annals of the Rheumatic Diseases
|
December 15, 2016
Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome
Benjamin A Fisher, Roland Jonsson, Troy Daniels, et al.
Human Molecular Genetics
|
April 6, 2017
A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA
Raphael Carapito, Jacques-Eric Gottenberg, Irina Kotova, et al.
Scandinavian Journal of Immunology
|
August 16, 2013
Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome
Gunnel Nordmark, Chuan Wang, Lilian Vasaitis, et al.
Rheumatology (Oxford, England)
|
September 19, 2020
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome
Maria Juarez, Nieves Diaz, Geoffrey I Johnston, et al.
Digital Health
|
October 3, 2025
Empowering patients: A multimodal digital health technology survey of patients with neurogenerative disorders and immune-mediated inflammatory diseases
Corina Maetzler, Johanna Graeber, Daniel Schmidtmann, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 138) with videos related to
Sort By:
Page
of 14
JMIR Formative Research
|
May 5, 2025
Characterizing Patient-Reported Fatigue Using Electronic Diaries in Neurodegenerative and Immune-Mediated Inflammatory Diseases: Observational Study
Adrien Bennetot, Rana Zia Ur Rehman, Robbin Romijnders, et al.
Neuromodulation : Journal of the International Neuromodulation Society
|
April 10, 2023
The Effects of Noninvasive Vagus Nerve Stimulation on Fatigue in Participants With Primary Sjögren's Syndrome
Jessica Tarn, Evelyn Evans, Emmanuella Traianos, et al.
Lancet (London, England)
|
August 3, 2024
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study
Benjamin A Fisher, Xavier Mariette, Athena Papas, et al.
The Lancet. Rheumatology
|
July 2, 2026
Interferon-α as a precision medicine tool in Sjögren's disease: a cohort and experimental medicine study
Deborah Forbes, Ivana Jorgacevic, Jessica Tarn, et al.
RMD Open
|
April 1, 2025
Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis
Leher Gumber, Fiona Rayner, Theophile Bigirumurame, et al.
Annals of the Rheumatic Diseases
|
December 15, 2016
Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren's syndrome
Benjamin A Fisher, Roland Jonsson, Troy Daniels, et al.
Human Molecular Genetics
|
April 6, 2017
A new MHC-linked susceptibility locus for primary Sjögren's syndrome: MICA
Raphael Carapito, Jacques-Eric Gottenberg, Irina Kotova, et al.
Scandinavian Journal of Immunology
|
August 16, 2013
Association of genes in the NF-κB pathway with antibody-positive primary Sjögren's syndrome
Gunnel Nordmark, Chuan Wang, Lilian Vasaitis, et al.
Rheumatology (Oxford, England)
|
September 19, 2020
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome
Maria Juarez, Nieves Diaz, Geoffrey I Johnston, et al.
Digital Health
|
October 3, 2025
Empowering patients: A multimodal digital health technology survey of patients with neurogenerative disorders and immune-mediated inflammatory diseases
Corina Maetzler, Johanna Graeber, Daniel Schmidtmann, et al.
Page
of 14